Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Online Discussions

Updated 20 November 2006
Printable version

Forum Discussion: Addressing Cardiovascular Risk Factors in Schizophrenia Patients

View article

In our Forum discussion “journal club” series, the editors of Schizophrenia Bulletin or Schizophrenia Research provide access to the full text of a recent article. A short introduction by a journal editor gets us started, and then it's up to our readers to share their ideas and insights, questions, and reactions to the selected paper. So read on…

Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, Lieberman JA. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006 Sep;86(1-3):15-22. Epub 2006 Aug 1.

Background Text
by Henry Nasrallah, University of Cincinnati College of Medicine, and Editor, Schizophrenia Research

A number of recent studies have highlighted the fact that people with schizophrenia have higher rates of cardiovascular and metabolic disorders (see SRF related news story), compounded by the fact that these patients are a medically underserved population in general. Recent studies report that persons with schizophrenia lose a mean of 32 years of life! (See Miller et al., 2006). This may be due to a dangerous combination of high rate of medical morbidity coupled with a high rate of non-treatment.

Using baseline data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) (see SRF related news story), we now report that although the non-treatment rate for diabetes in schizophrenia patients (30.2 percent) is comparable to that of the general population, non-treatment rates of hypertension (62.4 percent) and dyslipidemia (88.0 percent) are significantly higher.

One obvious barrier to remedying these disparities is the inadequacy of most health and social care systems to anticipate, identify, and treat metabolic dysfunction in psychiatric patients. Another is the failure of psychiatrists to intervene in these areas, as revealed by several recent studies (Newcomer et al., 2004; Buckley et al., 2005).

We invite you to offer novel, practical, and achievable solutions to these problems.

Submit a Comment on This Online Discussion
Make a comment on this live discussion. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
Enter the code as it is shown below:
This code helps prevent automated registrations.

Please note: A member needs to be both registered and logged in to submit a comment.


(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)


SRF News
SRF Comments
Text Size
Reset Text Size
Live Discussion FAQs

Webinar: A Webinar is a seminar conducted remotely over the Web. Attendees view the slides through their Web browser and hear the presentations over their own telephones.

Registration: All participants are to register by clicking on the "Register for the Webinar" link.

Access: After you register, you will receive an e-mail with a link to the Webinar and a phone number.
New Schizophrenia Fact Sheet for Patients and Families

Latest BBRF Research Breakthroughs

Visit our Facebook page and our Blog.

Support the Brain & Behavior Research Foundation Today.

Research Participants
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright